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Abstract
Background: Primary melanoma of the lung is an extremely rare pathological entity and sparsely
reported in the literature.
Case presentation: A case of primary malignant melanoma of the lung in a 41-year-old female is
reported. The clinical, radiological and histopathological features are discussed. The initial symptom
was cough, whereas the chest radiography showed a round opacity of the right lung. The computed
tomography of the chest revealed a well-demarcated mass lesion in the right upper lobe.
Endobronchial mass causing obstruction of the upper lobar bronchus was the bronchoscopic
finding. Patient underwent pneumonectomy. A diagnosis of melanoma was confirmed
postoperatively after the immunohistochemistry. Primary nature of the tumour in the lung results
from the demonstration of characteristic junctional pattern of melanoma cells beneath the
bronchial epithelium on histopathology, and from exclusion of other potential primary sites in the
clinical, paraclinical and laboratory examination.
Conclusions:  Primary melanoma of the lung represents a rare pathological entity. Careful
interpretation of histopathological information in correlation with all other findings from clinical
and paraclinical studies can establish a diagnosis. Follow-up is necessary in order to diagnose
potential dissemination or secondary sites of the disease. Due to the small number of cases
reported in the literature, there is no experience on the management and the prognosis of the
disease, but surgical resection remains the cornerstone of the treatment.
Introduction
Malignant melanoma (MM) is a malignant tumour, aris-
ing from the pigment producing cells (melanosomes) of
the deeper layers of the skin (or the eye) and is the leading
cause of death attributable to skin lesions. It is usually
described as an irregular dark skin lesion that may have
areas of varying colour. The mucosal localizations, such as
in the oral cavity, oesophagus, larynx, the ano-genital
mucosa, and in ovarian cystic teratoma have been also
described.
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Primary MM of the lung is an uncommon neoplasm that
may be confused with more conventional types of lung
cancer. The proposed criteria for diagnosis are often diffi-
cult to be fulfilled, and the lesion is characterised by a
poor prognosis.
More than 30 cases have been reported in the literature,
but not all of them meet the requested criteria. Particu-
larly, an extrapulmonary origin of the tumour has to be
excluded before considering this diagnosis, metastasis
from an occult primary must be convincingly excluded
and the tumour should confirm to laid guidelines [1-4].
The case report seems to fulfil the criteria to be considered
in the little group of definite primary melanoma of the
lower respiratory tract.
Case Report
A 41-year-old Greek non-smoker female presented with
respiratory symptoms including a cough which did not
improve with symptomatic treatment. She gave a past his-
tory of tuberculous pleurisy at the age of 11 years.
Chest radiograph showed a round opacity in the right
lung (Figure 1) and computed tomography revealed a
well-demarcated mass lesion in the right upper lobe
extending from the lateral chest wall to the hilum. She was
admitted for pneumonectomy with a provisional diagno-
sis of bronchogenic carcinoma.
No additional abnormalities were observed on subse-
quent detailed metastatic work-up including computed
tomography of brain and abdomen and whole body bone
scintigraphy. Bronchoscopy revealed an endobronchial
mass obstructing right upper lobe bronchus almost
totally. Tissue sampling resulted in histopathological
diagnosis of non-small-cell lung carcinoma (NSSLC),
probably epidermoid. She was submitted to thoracotomy
and a solid neoplasm extending from the hilum was
found. A pneumonectomy with mediastinal lymph node
dissection was carried out.
On gross examination of the resected specimen a darkly
pigmented neoplasm with solid growth pattern was seen.
The tumour was submucosal and endobronchial with
extension into the peribronchial soft tissue. Initial
interpretations of gross findings included carcinoid
tumour, non-small-cell carcinoma, and MM. Histologi-
cally the tumour was composed predominantly of epithe-
lioid tumour cells, junctional change and mitotic activity
with characteristic nesting of malignant cells beneath the
bronchial epithelium was also seen suggesting a diagnosis
of MM (Figure 2). The cells were arranged in alveolar pat-
tern (figure 3). The presence of MM was confirmed by
positive immunohistochemichal reaction with antibodies
to S-100 protein (Figure 4), and melanoma associated
monoclonal antibody HMB45, whereas cytokeratin, CAM
5.2, and chromogranin were negative. No bronchial in situ
component was detected. There were no mediastinal
lymph nodes metastases.
Considering the possibility of pulmonary metastasis of
malignant melanoma a detailed cutaneous, mucosal and
ophthalmic examination was carried out. This failed to
show any extrapulmonary disease. A pan endoscopy
(colonoscopy; upper gastrointestinal scopy) too failed to
detect any other possible primary tumour. Patient was
Thoracic radiography showing the mass of the right lung Figure 1
Thoracic radiography showing the mass of the right lung.
photomicrograph of the polypoidal mass of malignant  melanoma showing endobronchial tumor with mucosal  invasion Figure 2
photomicrograph of the polypoidal mass of malignant 
melanoma showing endobronchial tumor with mucosal inva-
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started on adjuvant α-interferon postoperatively for 6
months, and is living disease free for 18 months after the
surgery.
Discussion
Primary MM of the lung is a very rare neoplasm, account-
ing for 0.01% of all lung tumours [3]. It is frequently
endobronchial and manifest with symptoms of cough,
haemoptysis, postobstructive pneumonia, lobar collapse
or atelectasis. In 30% of the cases primary MM of the lung
is an incidental finding on chest radiography [4].
These clinical observations pertain to a series of 19
patients reviewed in 1999 with pathology compatible
with primary MM of the lung [4].
The clinical and radiological appearance is similar to lung
cancer, which is usually the preoperative diagnosis, as in
the present case. A preoperative computerised tomo-
graphic (CT) guided fine needle aspiration cytology
(FNAC) is of help in such situation.
The final diagnosis of a primary MM of the lung is estab-
lished based on clinical, radiological and pathological
findings. The proposed criteria for diagnosis of primary
MM include the following [5-7]:
1. Junctional changes like "dropping off" or "nesting" of
melanoma cells just beneath the bronchial epithelium.
2. Invasion of the bronchial epithelium by melanoma
cells.
3. Malignant melanoma associated with these epithelial
changes.
4. A solitary lung tumour.
5. No history of a cutaneous, mucous membrane or ocular
melanoma.
6. Absence of any other detectable tumour at the time of
diagnosis.
The present case fulfils the aforementioned diagnostic cri-
teria. The pathogenesis of primary MM of the lung is not
understood. There exist several theories to explain its
occurrence. One of them hypothesises that melanocytes
exist throughout the body as cells of a dispersed neuroen-
docrine system. Normally, melanocytes migrate to the
epidermis and the dermoepidermal junction of the skin,
but they may migrate to the visceral during embryogene-
sis. This has been suggested for the oesophagus and the
larynx and may be the case in lung too [1]. The residual
primitive melanoblasts, which share a common origin
with other melanoblasts located in the trachea, oesopha-
gus, and pharynx, give rise to MM of the lung [4,5,8].
Their origin from neuroectoderm is also said to be a cause
for their lower incidence in endodermal epithelium [9].
The other theory emphasizes that melanoma cells may
derive from a pluripotent stem cell.
The main differential diagnosis is melanocytic carcinoid
tumour, melanotic paraganglioma, melanotic schwan-
noma and pulmonary metastasis of a malignant
melanoma. These tumours can often be excluded by
Photomicrograph showing malignant melanoma cells in alveo- lar pattern (Hematoxylin-Eosin ×400) Figure 3
Photomicrograph showing malignant melanoma cells in alveo-
lar pattern (Hematoxylin-Eosin ×400).
Photomicrograph showing immunohistochemical staining of  melanoma cells with antibody S-100 (Avidin-Biotin Complex  ×400) Figure 4
Photomicrograph showing immunohistochemical staining of 
melanoma cells with antibody S-100 (Avidin-Biotin Complex 
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histopathological and immunohistochemical staining
combined with a good clinical history and examination of
the patient [2].
Treatment of choice is surgical resection of the tumour
with an oncologically adequate margin, as is lobectomy or
pneumonectomy. Furthermore, the central pulmonary
position of the lesion is a criterion of inclusion in primary
MM of the lung [3]. It is noteworthy that recurrence man-
ifested in two cases of segmental resection, while lymph
node involvement at the time of the operation did not
preclude long-term survival.
The role of postoperatively adjuvant chemotherapy or
radiotherapy either singly or in combination is not
known. Radiotherapy has been tried in mucosal
melanoma of the head and neck [9] with disappointing
results. Chemotherapy has been used mainly for pallia-
tion only [9]. The present case received adjuvant inter-
feron α.
The prognosis is rather poor, but existing data are not
enough to conclude with conviction. Long-term survival
was achieved in two cases in the past (10 years and 11
years) after lobectomy and pneumonectomy respectively
[10,11]. Prompt evaluation and close follow-up of the
patient is proposed in order to diagnose metastatic dis-
semination and to improve outcome.
Conclusions
Although rare, primary MM of the lung should be consid-
ered in the differential diagnosis of primary bronchial
tumours of the lung as an extremely rare alternative. Reli-
able data about clinical behaviour, tumour markers,
diagnostic modalities and prognostic factors do not exist
because of lack of large series. Most of the reports are of
single cases of no more than two cases [3]. Histopatholog-
ical and clinical criteria have been proposed and should
be applied in order to characterize a tumour as primary
MM of the lung.
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